Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Long-term lung issues and lower quality of life plague COVID-19 survivors, new study warns

New research in Scientific Reports reveals that COVID-19 survivors, especially those who had severe or critical illness, face long-term lung complications and a reduced quality of life. The study recommends 6-monthly pulmonary function tests for these survivors to monitor for chronic lung damage.

15 Oct 2023

Cerba Research expands expertise and global reach to support drug development

Cerba Research is transforming into a multi-specialist and central laboratory company, providing research organisations with even greater access to exceptional scientific and technical teams in multiple therapeutic areas for drug and vaccine development.

14 Oct 2023

New insights into coronavirus E channel could lead to antiviral drugs

The genome of the SARS-CoV-2 virus encodes 29 proteins, one of which is an ion channel called E. This channel, which transports protons and calcium ions, induces infected cells to launch an inflammatory response that damages tissues and contributes to the symptoms of Covid-19.

13 Oct 2023

The new vaccines and you: Americans better armed than ever against the winter blechs

Last year's "triple-demic" marked the beginning of what may be a new normal: a confluence of respiratory infections — RSV, influenza, and covid-19 — will surge as the weather cools each year.

13 Oct 2023

Moderna's updated COVID-19 vaccine for Autumn 2023 outperforms in cost and clinical impact

Moderna's updated mRNA-1273.815 COVID-19 vaccine shows promising results in reducing symptomatic cases, hospitalizations, and deaths in high-risk and older adults in Germany. The study finds the vaccine to be more cost-effective and clinically beneficial than both no vaccination and Pfizer's XBB.1.5 BNT162b2 vaccine.

12 Oct 2023

EVScape: New tool to forecast which SARS-CoV-2 variants could dodge our immunity

Researchers have developed EVScape, a predictive tool that identifies which SARS-CoV-2 strains are most likely to evade host immunity. Utilizing a deep generative model and structural information, the tool offers early warning about viral variants, aiding in the timely development of effective vaccines and treatments.

12 Oct 2023

New clinical trial shows simple way to save thousands of units of blood every year

A world-first clinical trial published in JAMA could provide an easy way to save tens of thousands of units of blood every year in Canada and much more worldwide.

12 Oct 2023

‘I’m so burned out’: Fighting to see a specialist amplified pain for Riverside County woman

Teresa Johnson can't escape the pain. It's as if she's getting pierced by needles all over her body, all at once. At night, she sometimes jolts out of sleep thinking bedbugs are attacking her. But it's just the unfailing pain — day in and day out.

12 Oct 2023

OrganaBio launches new division to meet growing demand for decentralized clinical trial support

OrganaBio, the Contract Technology Development and Manufacturing Organization (CTDMO) specializing in solutions for cell and immunotherapy development, today announces the official launch of Cell Processing and Cryopreservation (CPC) Services, a new division of OrganaBio.

12 Oct 2023

School cycling program linked to improved mental well-being in adolescents

Physical activity has positive effects on mental health and yet, activity rates are declining. This is particularly worrying because the mental well-being of teenagers continues to deteriorate. In the US, one in six school children is diagnosed with some type of mental disorder.

12 Oct 2023

Can living near parks and lakes boost your mental health? A 10-year study says yes

A decade-long study involving 2.3 million adults in Wales found that greater exposure to green and blue spaces (GBS) is linked to reduced rates of common mental disorders (CMD), particularly among socio-economically deprived individuals. The findings suggest that increased access to GBS not only has mental health benefits but can also offer additional ecological advantages, informing policymakers on the value of GBS in community planning.

12 Oct 2023

Genetically edited chickens show resistance to avian influenza in landmark study

Researchers use CRISPR technology to create chickens resistant to avian influenza, targeting specific genes to inhibit viral replication. The study reveals both the promise and complexities of using genetic editing as a disease control strategy, also shedding light on influenza's adaptability.

11 Oct 2023

Is "double jeopardy" of midlife and old age stalling America's life expectancy?

Study reveals that the stagnation in U.S. life expectancy since 2010 is more significantly impacted by increased mortality rates in those above 65 years old than in working-age adults. Termed "double jeopardy," this finding highlights the urgent need for targeted interventions to improve health outcomes across age groups.

11 Oct 2023

Virtual psychotherapy improved continuity of care during COVID-19 pandemic

The rapid transition to virtual care that occurred with the onset of the COVID-19 pandemic resulted in better continuity of psychotherapy visits compared to prior to the pandemic when almost all visits were in-person, according to new research published in Psychiatric Services, a journal of the American Psychiatric Association.

11 Oct 2023

Pandemic News and Research

Further Reading

Long-term lung issues and lower quality of life plague COVID-19 survivors, new study warns

Cerba Research expands expertise and global reach to support drug development

New insights into coronavirus E channel could lead to antiviral drugs

The new vaccines and you: Americans better armed than ever against the winter blechs

Moderna's updated COVID-19 vaccine for Autumn 2023 outperforms in cost and clinical impact

EVScape: New tool to forecast which SARS-CoV-2 variants could dodge our immunity

New clinical trial shows simple way to save thousands of units of blood every year

‘I’m so burned out’: Fighting to see a specialist amplified pain for Riverside County woman

OrganaBio launches new division to meet growing demand for decentralized clinical trial support

School cycling program linked to improved mental well-being in adolescents

Can living near parks and lakes boost your mental health? A 10-year study says yes

Genetically edited chickens show resistance to avian influenza in landmark study

Is "double jeopardy" of midlife and old age stalling America's life expectancy?

Virtual psychotherapy improved continuity of care during COVID-19 pandemic

New AI tool predicts future viral variants using evolutionary, biological information

How were antibiotics used during the COVID-19 pandemic?

Adaptability and promising potential of synthetic information in healthcare

Mental health problems may lead to obesity, other health problems for Latinx teens

Epidemic: Bodies remember what was done to them

Mental Health as a Universal Human Right: NAMI's Mission on World Mental Health Day

Best practices - optimize qPCR processes for pathogen detection eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News